Nature Reviews Materials 1, 16069 (2016). Published 7 September 2016; corrected 9 September 2016.
In the originally published HTML version of this article, Gert Storm's surname was incorrectly spelled.
This has been corrected in the HTML version.
Additional information
The online version of the original article can be found at 10.1038/natrevmats.2016.69
Rights and permissions
About this article
Cite this article
Lammers, T., Kiessling, F., Ashford, M. et al. Erratum: Cancer nanomedicine: is targeting our target?. Nat Rev Mater 1, 16076 (2016). https://doi.org/10.1038/natrevmats.2016.76
Published:
DOI: https://doi.org/10.1038/natrevmats.2016.76
This article is cited by
-
Lessons from immuno-oncology: a new era for cancer nanomedicine?
Nature Reviews Drug Discovery (2017)